Assessment of Biomarker Testing for Lung Cancer Screening Eligibility

JAMA Netw Open. 2020 Mar 2;3(3):e200409. doi: 10.1001/jamanetworkopen.2020.0409.

Abstract

This exploratory study analyzes the cost-effectiveness of incorporating biomarkers into eligibility assessment for lung screening.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / metabolism
  • Cost-Benefit Analysis
  • Early Detection of Cancer / economics*
  • Eligibility Determination
  • Humans
  • Lung Neoplasms / diagnosis*
  • Patient Selection*
  • Smoking

Substances

  • Biomarkers